Informações:
Falhas:
Palavras-chave
Antineoplásicos ×
- Clinical Trial (2)
- Clinical Trial, Phase II (2)
- Eligibility Determination (2)
- Lymphoma, B-Cell (1)
- Hospice Care (1)
- Carcinoma, Squamous Cell (1)
- Conjunctival Neoplasms (1)
- Head and Neck Neoplasms (1)
- Otorhinolaryngologic Diseases (1)
- Palliative Care (1)
Índice
Modelos de dados selecionados
Deve ter sessão iniciada para selecionar vários modelos de dados e para os transferir ou analisar.
3 Resultados da pesquisa.
Grupos de itens: Date, TT1. Type of therapy, TT2. Number of previous treatments, TT3. Indications, TT4. Agents/Regime/Modus, TT5. Medical indication assessed by, TT6. Palliative prognostic index PPI in pre-treatment/ starting the new indicated tumor treatment, TT7. Was proceding/start of tumor therapy based on consensus in the palliative team?, TT8. What was the subjective success of the tumor therapy?, TT9. Was the tumor therapy determined early?, TT10. If yes, what were the reasons for the discontinuation of tumor therapy?, TT11. Was discontinuation of tumor therapy based on consensus in the palliative team?, TT12. Who completes this questionnaire?
Grupos de itens: Inclusion Criteria, Exclusion Criteria
Grupos de itens: Inclusion Criteria, Exclusion Criteria